Saudi Arabia Influenza Treatment Market Size & Outlook
Saudi Arabia influenza treatment market, 2018-2030 (US$M)
Related Markets
Saudi Arabia influenza treatment market highlights
- The Saudi Arabia influenza treatment market generated a revenue of USD 62.2 million in 2023 and is expected to reach USD 65.0 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 0.6% from 2024 to 2030.
- In terms of segment, oseltamivir phosphate was the largest revenue generating treatment in 2023.
- Baloxavir Marboxil is the most lucrative treatment segment registering the fastest growth during the forecast period.
Influenza treatment market data book summary
| Market revenue in 2023 | USD 62.2 million |
| Market revenue in 2030 | USD 65.0 million |
| Growth rate | 0.6% (CAGR from 2023 to 2030) |
| Largest segment | Oseltamivir phosphate |
| Fastest growing segment | Baloxavir Marboxil |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Peramivira, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate |
| Key market players worldwide | Novartis AG ADR, Roche Holding AG, BioCryst Pharmaceuticals Inc, Sanofi SA, GSK PLC, GSK PLC ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Co Ltd, AstraZeneca PLC |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.1% of the global influenza treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia influenza treatment market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 26.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Influenza Treatment Market Scope
Influenza Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia influenza treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza treatment market will help companies and investors design strategic landscapes.
Oseltamivir phosphate was the largest segment with a revenue share of 27.65% in 2023. Horizon Databook has segmented the Saudi Arabia influenza treatment market based on peramivira, zanamivir, baloxavir marboxil, oseltamivir phosphate covering the revenue growth of each sub-segment from 2018 to 2030.
- Saudi Arabia Influenza Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
- Peramivira
- Zanamivir
- Baloxavir Marboxil
- Oseltamivir Phosphate
- Others
- Saudi Arabia Influenza Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Others
- Saudi Arabia Influenza Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Reasons to subscribe to Saudi Arabia influenza treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia influenza treatment market databook
-
Our clientele includes a mix of influenza treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia influenza treatment market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia influenza treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia influenza treatment market size, by treatment, 2018-2030 (US$M)
Saudi Arabia Influenza Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
